These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21494160)

  • 1. Effects of valsartan on neuroprotection and neurogenesis after ischemia.
    Wakai T; Yoshioka H; Yagi T; Kato T; Kinouchi H
    Neuroreport; 2011 Jun; 22(8):385-90. PubMed ID: 21494160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valsartan attenuates oxidative stress and NF-κB activation and reduces myocardial apoptosis after ischemia and reperfusion.
    Wu B; Lin R; Dai R; Chen C; Wu H; Hong M
    Eur J Pharmacol; 2013 Apr; 705(1-3):140-7. PubMed ID: 23499691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.
    Iwai M; Liu HW; Chen R; Ide A; Okamoto S; Hata R; Sakanaka M; Shiuchi T; Horiuchi M
    Circulation; 2004 Aug; 110(7):843-8. PubMed ID: 15289370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes.
    Qiang G; Zhang L; Yang X; Xuan Q; Shi L; Zhang H; Chen B; Li X; Zu M; Zhou D; Guo J; Yang H; Du G
    Eur J Pharmacol; 2012 Jun; 685(1-3):156-64. PubMed ID: 22546234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
    Chan P; Liu IM; Tzeng TF; Yang TL; Cheng JT
    Diabetes Obes Metab; 2007 Jan; 9(1):39-49. PubMed ID: 17199717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
    Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
    J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporary pretreatment with the angiotensin II type 1 receptor blocker, valsartan, prevents ischemic brain damage through an increase in capillary density.
    Li JM; Mogi M; Iwanami J; Min LJ; Tsukuda K; Sakata A; Fujita T; Iwai M; Horiuchi M
    Stroke; 2008 Jul; 39(7):2029-36. PubMed ID: 18436887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
    Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
    Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
    Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL
    J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
    Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
    Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection of gamma-aminobutyric acid receptor agonists via enhancing neuronal nitric oxide synthase (Ser847) phosphorylation through increased neuronal nitric oxide synthase and PSD95 interaction and inhibited protein phosphatase activity in cerebral ischemia.
    Zhou C; Li C; Yu HM; Zhang F; Han D; Zhang GY
    J Neurosci Res; 2008 Oct; 86(13):2973-83. PubMed ID: 18512761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the angiotensin II type 1 receptor antagonist valsartan on the expression of superoxide dismutase in hypertensive patients.
    Yang HY; Kao PF; Chen TH; Tomlinson B; Ko WC; Chan P
    J Clin Pharmacol; 2007 Mar; 47(3):397-403. PubMed ID: 17322151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective role of angiotensin II type 2 receptor after transient focal ischemia in mice brain.
    Miyamoto N; Zhang N; Tanaka R; Liu M; Hattori N; Urabe T
    Neurosci Res; 2008 Jul; 61(3):249-56. PubMed ID: 18455256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New basic science initiatives with the angiotensin II receptor blocker valsartan.
    de Gasparo M
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S3-5. PubMed ID: 17199210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valsartan improves mitochondrial function in hearts submitted to acute ischemia.
    Monteiro P; Duarte AI; Gonçalves LM; Providência LA
    Eur J Pharmacol; 2005 Aug; 518(2-3):158-64. PubMed ID: 16055115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
    Kagawa T; Takao T; Horino T; Matsumoto R; Inoue K; Morita T; Hashimoto K
    Nephrology (Carlton); 2008 Jun; 13(4):309-15. PubMed ID: 18331441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage.
    Iwai M; Chen R; Ide A; Iwanami J; Tomochika H; Tomono Y; Mogi M; Horiuchi M
    J Hypertens; 2006 Oct; 24(10):2023-31. PubMed ID: 16957563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin AT1 receptor blockers suppress ischemia/reperfusion-induced gastric injury in rats.
    Nakagiri A; Sunamoto M; Murakami M
    Inflammopharmacology; 2007 Aug; 15(4):171-4. PubMed ID: 17701020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
    Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism.
    Mitchell A; Rushentsova U; Siffert W; Philipp T; Wenzel RR
    Clin Pharmacol Ther; 2006 Mar; 79(3):274-81. PubMed ID: 16513451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.